Table 3.

The proportion of patients with recurrent gout, increased risk of flares, and flares per gout flare patient, according to SUA level.

StudyPeriod of Flare Measure, YrsSUA Level Category, mg/dlPatients with FlaresFlares per Gout Flare Patient, Mean (SD)
%Ratio of %
Estimates from clinically confirmed gout studies
Perez-Ruiz, et al224.6 (mean)≥ 6.0 to < 7.03.7Referent
≥ 7.0 to < 8.221.35.8
≥ 8.3 to < 9.350.813.7
≥ 9.361.316.6
Shoji, et al23> 1< 6.012.0Referent
≥ 6.0 to < 9.047.74.0
≥ 9.089.57.5
Estimates from retrospective database studies
Halpern, et al342< 6.046.4Referent1.3 (0.6)
≥ 6.0 to < 9.061.21.31.5 (0.8)
≥ 9.063.81.41.7 (1.0)
Sarawate, et al355< 6.023.0Referent
≥ 6.0 to < 8.033.01.4
≥ 8.045.02.0
Wu, et al361< 6.026.9Referent1.5 (0.8)
≥ 6.0 to < 9.043.41.61.6 (0.9)
≥ 9.054.52.01.7 (1.2)
  • SUA: serum uric acid.